Stratmont Industries Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Stratmont Industries Ltd is ₹ 51.3 as of 23 Oct 15:30 . The P/E Ratio of Stratmont Industries Ltd changed from 527.5 on March 2021 to 63.5 on March 2026 . This represents a CAGR of -29.73% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Stratmont Industries Ltd changed from ₹ 3.69 crore on March 2021 to ₹ 166.57 crore on March 2026 . This represents a CAGR of 88.70% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Stratmont Industries Ltd for the Jun '26 is ₹ 44.18 crore as compare to the Mar '26 revenue of ₹ 63.64 crore. This represent the decline of -30.58% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Stratmont Industries Ltd for the Jun '26 is ₹ 0.9 crore as compare to the Mar '26 ebitda of ₹ 0.96 crore. This represent the decline of -6.25% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Stratmont Industries Ltd changed from ₹ 0.36 crore to ₹ 0.25 crore over 9 quarters. This represents a CAGR of -14.96% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Stratmont Industries Ltd changed from 10.88 % on March 2026 to 10.88 % on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Stratmont Industries Ltd

Stratmont Industries Limited was initially incorporated as 'Raigarh Paper & Board Mills Limited' in 1984.
The name of the Company was changed from Raigarh Paper & Board Mills Limited to Chhattisgarh Industries Limited in April 2009 and again changed from Chhattisgarh Industries Limited to Stratmont Industries Limited on December,2016.
Earlier, the Company engaged into sale of sarees.
Company is engaged in a diverse range of industrial, manufacturing, trading, and infrastructure related activities across India and globally.
This include metal casting and processing, steel and allied industries, energy and power, infrastructure & construction, real estate and land development, commodities & industrial raw materials, mining & heavy industries. The Company attained the industrial expertise and are recognized for Manufacturing and Supplying of LAM Coke with the production capacity of 36,000 Metric Ton Per Annum (MTPA) manufacturing unit at Bhachau, Kachchh District in Gujarat.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Stratmont Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Stratmont Industries Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Stratmont Industries Ltd is 146 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Stratmont Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Stratmont Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Stratmont Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Stratmont Industries Ltd stock price is INR ₹51.3. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Stratmont Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Stratmont Industries Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.